Riboxin - instructions for use, reviews, analogs and formulations (200 mg tablets, 200 mg capsules, injections injections) drugs for the treatment of myocardial infarction, hepatitis and other diseases in adults, children and pregnancy
In this article, you can read the instructions for using the drug Riboxin. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Riboxin in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Riboxin analogs in the presence of existing structural analogues.Use for the treatment of myocardial infarction, hepatitis and other metabolic diseases in adults, children, as well as during pregnancy and lactation.
Riboxin - refers to the group of drugs that regulate metabolic processes. The drug is a precursor of the synthesis of purine nucleotides: adenosine triphosphate and guanosine triphosphate. The active substance of the drug is Inosine.
Has antihypoxic, metabolic and antiarrhythmic effect. Increases the energy balance of the myocardium, improves coronary circulation, prevents the consequences of intraoperative kidney ischemia. It takes a direct part in the exchange of glucose and promotes the activation of metabolism in conditions of hypoxia and in the absence of adenosine triphosphate.
Activates the metabolism of pyruvic acid to ensure a normal process of tissue respiration, and also promotes the activation of xanthine dehydrogenase. Stimulates the synthesis of nucleotides, enhances the activity of certain enzymes of the Krebs cycle. Penetrating into cells, increases the energy level, has a positive effect on the metabolic processes in the myocardium, increases the strength of the heart contractions and promotes more complete relaxation of the myocardium in diastole,as a result of which the shock volume of blood increases.
Reduces platelet aggregation, activates the regeneration of tissues (especially the myocardium and mucous membrane of the gastrointestinal tract.
Pharmacokinetics
It is well absorbed in the gastrointestinal tract. Metabolised in the liver with the formation of glucuronic acid and its subsequent oxidation. In a small amount is excreted by the kidneys.
Indications
- IHD;
- myocardial dystrophy;
- condition after myocardial infarction;
- congenital and acquired heart defects;
- heart rhythm disturbances, especially with glycosidic intoxication;
- myocarditis;
- dystrophic changes of the myocardium after heavy physical exertion and transferred infectious diseases or due to endocrine disorders;
- hepatitis;
- cirrhosis of the liver;
- fatty degeneration of the liver, incl. caused by alcohol or drugs;
- prevention of leukopenia during radioactive irradiation;
- operations on an isolated kidney (as a means of pharmacological protection in the temporary absence of circulation in the operated organ).
Forms of release
The tablets covered with a cover of 200 mg.
Capsules 200 mg.
Solution for intravenous administration (injections in ampoules for injection) 20 mg / ml.
Instructions for use and dosing regimen
Tablets, capsules
Assign adults inside, before eating.
The daily intake for oral administration is 0.6-2.4 g. In the first days of treatment, the daily dose is 0.6-0.8 g (200 mg 3-4 times a day). In case of good tolerance, the dose is increased (2-3 days) to 1.2 g (0.4 g 3 times a day), if necessary - up to 2.4 g per day.
The duration of the course is from 4 weeks to 1.5-3 months.
With urocoppororphy, the daily dose is 0.8 g (200 mg 4 times a day). The drug is taken daily for 1-3 months.
Ampoules
When administered, the initial daily dose is 600-800 mg, then the dose is gradually increased to 2.4 g per day in 3-4 doses.
With intravenous (jet or drip in the form of a dropper), the initial dose is 200 mg once a day, then the dose is increased to 400 mg 1-2 times a day.
The duration of the course treatment is set individually.
Side effect
- allergic reactions in the form of urticaria, skin itching, skin hyperemia (drug withdrawal required);
- increased concentration of uric acid in the blood and exacerbation of gout (with prolonged use).
Contraindications
- hypersensitivity to the drug;
- gout;
- hyperuricemia;
- children under 3 years;
- fructose intolerance and glucose / galactose absorption disorder or sugarase / isomaltase deficiency.
Application in pregnancy and lactation
The safety of the drug Riboxin during pregnancy and lactation is not established. Riboxin is contraindicated during pregnancy. For the duration of treatment with Riboxin, breastfeeding should be stopped.
Use in children
Contraindicated in children under 3 years.
special instructions
During the treatment with Riboxin, the concentration of uric acid in the blood and urine should be monitored.
Information for patients with diabetes: 1 tablet of the drug corresponds to 0.00641 units of bread.
Does not affect the ability to drive vehicles and manage mechanisms that require increased concentration.
Drug Interactions
Immunosuppressants (azathioprine, antilympholine, cyclosporine, thymodepressin, etc.) with simultaneous use reduce the effectiveness of Riboxin.
Analogues of the drug Riboxin
Structural analogs for the active substance:
- Inosie-F;
- Inosine;
- Inosine-Eskom;
- Riboxin bufus;
- Riboxin-Vial;
- Riboxin-LexT;
- Riboxin-Ferein;
- Riboxin injection 2%;
- Ribonosine.
Similar medicines:
Other medicines:
- Metrogil - instructions for use, reviews, analogs and forms of release (tablets 200 mg and 400 mg, gel vaginal 1% plus and Denta for dentistry and external 1% solution) for the treatment of infections in adults, children and pregnancy
- Polyoxidonium - instructions for use, analogs, reviews and release forms (tablets 12 mg, suppositories 6 mg and 12 mg, injections in ampoules for injection of 3 mg and 6 mg) of the drug for the treatment of immunodeficiency in adults, children and pregnancy
- Doxycycline - instructions for use, analogs, reviews and release forms (capsules 100 mg, injections in ampoules for injection (lyophilizate)) drugs for the treatment of syphilis, ureaplasma and other infections in adults, children and pregnancy